Citation only
via OpenAlex
Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease
Mario Nieto, Mina Königsberg, Alejandro Silva‐Palacios
Biogerontology · 2023 · ▲ 36 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s10522-023-10068-5
- Canonical
- link ↗
- Fetched
- 2026-06-18 MST
Cite this
APA
Nieto, M., Königsberg, M., & Silva‐Palacios, A. (2023). Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease. <em>Biogerontology</em>. https://doi.org/10.1007/s10522-023-10068-5
Vancouver
Nieto M, Königsberg M, Silva‐Palacios A. Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease. Biogerontology. 2023. doi:10.1007/s10522-023-10068-5.
BibTeX
@article{mario2023Querce,
title = {Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease},
author = {Mario Nieto and Mina Königsberg and Alejandro Silva‐Palacios},
journal = {Biogerontology},
year = {2023},
doi = {10.1007/s10522-023-10068-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Advances in experimental medicine and biology 2020
Citation only
Inflammation, Frailty and Cardiovascular Disease
Cell Death and Differentiation 2020
Open access · OA
Autophagy and disease: unanswered questions
EBioMedicine 2020
Open access · CC-BY
Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456
Acta Pharmacologica Sinica 2020
Open access · OA
Drp1-dependent mitochondrial fission in cardiovascular disease
Trends in Endocrinology and Metabolism 2023
Open access · OA
Blood-based bioenergetics: a liquid biopsy of mitochondrial dysfunction in disease
Phytomedicine 2015
Citation only